Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial.
about
Gallbladder Cancer in the 21st Century.Advances in systemic therapy for advanced pancreatobiliary malignanciesTargeted therapy in biliary tract cancers-current limitations and potentials in the future.Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decadesGemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trialsPhase II study of gemcitabine and cisplatin in advanced biliary tract cancer.Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancerEfficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma.A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer.Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective studyA phase I study for adjuvant chemotherapy of gemcitabine plus S-1 in curatively resected patients with biliary tract cancer: adjusting the dose of adjuvant chemotherapy according to the surgical procedures.A phase II trial of fixed-dose rate gemcitabine plus capecitabine in metastatic/advanced biliary tract cancer patients.Outcome of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) chemotherapy and analysis of prognostic factors in patients with refractory advanced biliary tract cancer.Hepatic intra-arterial chemotherapy in patients with advanced primary liver tumours.A phase I study of sorafenib, oxaliplatin and 2 days of high dose capecitabine in advanced pancreatic and biliary tract cancer: a Wisconsin oncology network study.A multi-institution phase II study of gemcitabine/cisplatin/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002).Phase II study of gemcitabine and S-1 combination chemotherapy in patients with metastatic biliary tract cancer.Long term responders to palliative chemotherapy for advanced biliary tract cancer.Chemotherapy in patients with hepatobiliary cancers and abnormal hepatic functionChemotherapy and targeted therapy for gall bladder cancer.Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium study.Multi-disciplinary treatment for cholangiocellular carcinoma.Update on the management of cholangiocarcinoma.A phase II trial of the proteasome inhibitor bortezomib in patients with advanced biliary tract cancers.Systemic Therapy of Cholangiocarcinoma.Guidelines for chemotherapy of biliary tract and ampullary carcinomasPrecision hepatic arterial irinotecan therapy in the treatment of unresectable intrahepatic cholangiocellular carcinoma: optimal tolerance and prolonged overall survival.Routine histopathology for carcinoma in cholecystectomy specimens not evidence based: a systematic review.Gemcitabine and s-1 combination chemotherapy in patients with advanced biliary tract cancer: a retrospective study.Current management of gallbladder carcinoma.NCCN clinical practice guidelines in oncology: hepatobiliary cancersTumors of ampulla of Vater: A case series and review of chemotherapy optionsGallbladder cancer: expert consensus statement.SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma.Is an aggressive surgical approach worthwhile in biliary cancer?Chemotherapy for advanced cholangiocarcinoma: what is standard treatment?Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial.Cholangiocarcinoma: Biology, Clinical Management, and Pharmacological Perspectives.Emerging drugs for biliary cancer.Thromboembolism in gastrointestinal cancers.
P2860
Q26784174-E429FCE5-21EC-4BB5-9629-3BE4CE455FC9Q26822703-4DC3FE06-E45F-40E8-A5C7-A93F0C5AE209Q30234532-2009DDC0-B823-46D3-A679-78F5C347053DQ30300756-0F0BB908-9624-4EDE-8A88-817DAAA12B0FQ30318857-13E0AE7B-E0BD-498B-91CD-300B9511922DQ33371325-3DCB3B11-9F1A-4D87-96EB-CC1FAFF040C6Q33372640-9F8B0E2C-EA3F-4B1B-81BD-C7CDA99E7514Q33381056-F6E5318D-0042-4C5C-9049-FF031EEECAA2Q33391729-80C810EE-164C-46BC-BD52-2753871FFCA3Q33394065-AFDCE5DE-2B8A-402C-9AC7-35DD12EFD0C3Q33398969-7545FAFE-CC8A-42A3-B81D-D0F569CEBE8BQ33399656-CC0B23F5-9E76-4A9D-AAD1-4E766362C85EQ33402129-559014CD-FD2E-4252-9258-53218CBA8E9BQ33404756-6C86A482-C72C-4A9C-91B7-96F19426651BQ33404952-66F9CACE-F91A-4A87-BF30-FF0764D47C6BQ33419175-729A8FAA-9AB7-4AD1-94C2-416946F9739DQ33420043-D395524D-15EA-4372-AD49-48D30B1EE246Q33593193-DAFEF904-6A8C-4170-AC55-C40C962BC67CQ33593207-FE49AE42-CF3C-4A71-80FC-1AB05A3946ABQ33977171-27FFAB0E-0836-4F84-8561-46AE74FA64CDQ34048813-0653C2EA-73F5-49B1-B41F-F3DF4A846DC3Q34099099-5AE450C9-547C-4736-88EA-8A5D52F01E48Q34153255-6879EEC1-FEFC-4DEE-9A69-5B322AB35C84Q34307050-DDB44C6F-E334-48C2-8EC4-849A9936135EQ34551877-E1EEBD73-499D-4838-B6E5-0A1DACC6BC9FQ34588361-F8B121B2-DAF9-4C4B-9594-C13823909DB3Q34623728-7723E4FF-1DBB-48FF-AC5D-B75275551228Q34858544-95BBACAB-3116-456A-97C2-E26F18DE019DQ34999918-C1122BD8-25A6-41AF-8A98-776BEA6C6A4AQ35583920-299A3254-8348-4A5C-AED7-1889DD37388DQ35703937-D11072DF-1681-4FBD-9846-53AF13CA0495Q35854505-F03EF832-E116-4FB3-AEA1-2582EF9A2C09Q35924976-F950705A-578E-41D9-AF58-23A61F3EA735Q35947011-0ED2774E-5A1E-4F09-8D51-657A2B52326CQ36397621-D62DBE80-C091-4111-BAF9-978C68ED8033Q36572534-5582C621-DE8B-479D-9A7C-68D3758C99EEQ36614800-1E5F2D70-792F-4EE1-BFBE-FFFA354AB172Q36962011-95722A48-E84A-4990-BEE2-579298D73EA3Q36989921-24E8408F-1134-4C62-9DC9-D5A0BF96E0C3Q37076622-9A9FA158-99F5-485E-B0D5-48E1E6212418
P2860
Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Combining gemcitabine and cape ...... iary cancer: a phase II trial.
@ast
Combining gemcitabine and cape ...... iary cancer: a phase II trial.
@en
type
label
Combining gemcitabine and cape ...... iary cancer: a phase II trial.
@ast
Combining gemcitabine and cape ...... iary cancer: a phase II trial.
@en
prefLabel
Combining gemcitabine and cape ...... iary cancer: a phase II trial.
@ast
Combining gemcitabine and cape ...... iary cancer: a phase II trial.
@en
P2093
P356
P1476
Combining gemcitabine and cape ...... iary cancer: a phase II trial.
@en
P2093
Gregory R Pond
Jennifer J Knox
Jessica Zhang
Lillian L Siu
Mahsan Nematollahi
Malcolm J Moore
P304
P356
10.1200/JCO.2005.51.008
P407
P50
P577
2005-04-01T00:00:00Z